Source: Annual Congress 2003 - Therapeutic procedures in interventional pulmonolgy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Daviskas, S. D. Anderson, K. Gomes, P. Briffa, B. Cochrane, H. K. Chan, I. H. Young (Sydney, Australia). Increase in health status after 12 days treatment with inhaled mannitol in patients with bronchiectasis. Eur Respir J 2003; 22: Suppl. 45, 2752

Member's Comments

No comment yet.

Related content which might interest you: Changes in the properties of sputum in patients with brochiectasis treated with inhaled manitol for 12 days - A pilot study Source: Annual Congress 2003 - Cellular and molecular mechanisms in epithelium injury and repair Year: 2003 Effects of switching inhaled medication from twice a day to once a day in patients with bronchial asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Salmeterol provides sustained health status improvement over 12 months in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 241s Year: 2002 Budesonide inhalation suspension improves the functional health status of paediatric asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 121s Year: 2001 Rescue-free days in patients with mild persistent asthma receiving montelukast sodium or an inhaled corticosteroid Source: Eur Respir J 2002; 20: Suppl. 38, 113s Year: 2002 Induced sputum in children with mild-moderate persistent asthma: the effect of inhaled corticosteroid treatment Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Induced sputum in children with persistent asthma: the effect of inhaled corticosteroid treatment Source: Eur Respir J 2006; 28: Suppl. 50, 258s Year: 2006 Annual systemic and inhaled corticosteroid exposures in US patients =4 years with asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006 The effects of an 8 week pulmonary rehabilitation programme in patients with bronchiectasis Source: Annual Congress 2008 - Pulmonary rehabilitation for non-COPD and severe COPD; field exercise testing Year: 2008 Effect of home intravenous antibiotic treatment on exercise capacity in children with cystic fibrosis Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Assessment of maximal airway response before and after inhaled corticosteriod treatment in new diagnosed asthma patients Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 Characteristics of COPD patients treated with inhaled corticosteroid in primary care Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Nebulized saline treatment in patients with concomitant asthma and bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006 A comparison of intravenous versus oral administration of corticosteroids in the treatment of patients admitted to the hospital with an exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004